MyAverix Finance
SHG · Healthcare
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613)
Drug Manufacturers - General
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-28, reported market cap is $3.21B, P/E ratio is 54.64, net margin is 3.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600613
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) — FAQ
What is Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's market cap?
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a reported market cap of $3.21B (data as of 2026-03-28).
What is 600613's P/E ratio?
The price-to-earnings (P/E) ratio for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) is 54.64 (data as of 2026-03-28).
Does Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A pay a dividend?
Dividend yield is not available in the current snapshot for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613). Check the MyAverix Finance app for the latest dividend data.
What sector is Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A in?
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is 600613 listed on?
600613 is listed on SHG.
What is Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's net margin?
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) reports a net margin of 3.3% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.